Coya Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 Aug 23 | BuyUS$3,620 | Ann Lee | Individual | 1,000 | US$3.62 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 0 | 0% |
Hedge Funds | 1,274,026 | 8.72% |
Individual Insiders | 2,285,998 | 15.7% |
Institutions | 2,766,540 | 18.9% |
General Public | 8,275,608 | 56.7% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 52.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,274,026 | US$11.8m | 114% | 0.47% | |||
949,338 | US$8.8m | 0% | no data | |||
847,490 | US$7.8m | 772% | no data | |||
678,863 | US$6.3m | -46.7% | 0.34% | |||
649,427 | US$6.0m | -37.1% | 2.52% | |||
395,048 | US$3.7m | 0% | no data | |||
391,291 | US$3.6m | 0% | no data | |||
333,826 | US$3.1m | 0% | no data | |||
165,016 | US$1.5m | 0% | no data | |||
125,996 | US$1.2m | 36.3% | no data | |||
110,095 | US$1.0m | 0% | no data | |||
100,000 | US$925.7k | 0% | 0.74% | |||
53,997 | US$499.9k | 148% | no data | |||
46,200 | US$427.7k | 0% | no data | |||
35,770 | US$331.1k | 0% | 0.02% | |||
31,457 | US$291.2k | 15,000% | no data | |||
25,467 | US$235.8k | 71.2% | no data | |||
22,479 | US$208.1k | 28.6% | no data | |||
21,101 | US$195.3k | 0% | 0.31% | |||
20,078 | US$185.9k | 0% | no data | |||
15,481 | US$143.3k | -4.01% | 0.03% | |||
10,000 | US$92.6k | 0% | no data | |||
10,000 | US$92.6k | 0% | no data | |||
7,000 | US$64.8k | 0% | no data | |||
2,000 | US$18.5k | 0% | no data |